CARDIOVASCULAR DISEASESHypercholesterolemia Awareness Raising Activities
Hypercholesterolemia is a condition that threatens public health and the leading cause of deaths worldwide. Hypercholesterolemia awareness raising activities are carried out to raise the awareness of physicians and subsequently patients about this issue.
DIABETESDiabetes, which is one of the most prevalent diseases today, is a chronic disease that lasts for life. Diabetes, which affects over 400 million people worldwide and over 7 million people in Turkey, is a growing health problem across the globe. Practices that make life with diabetes easier are of utmost importance for patients' lives. To support solutions within that frame, Sanofi conducts several activities.
Lighten Diabetes Patient’s Life (‘Sen Bul Diyabet Kolaylaşsın’)
This project aims to bring to light the innovative ideas or inventions of university students that could facilitate the lives of individuals with diabetes. The call for the project was made on the www.senbuldiyabetkolaylassin.com website and during face-to-face activities at universities. More than 100 project applications were made to this competition organized for the 5th time in 2018. Fifteen projects selected as finalists found the opportunity to collaborate with Kworks (Koç University's Acceleration and Incubation Center for Entrepreneurs) and implement their projects under the “Entrepreneur Acceleration Program” in six categories of need. In this context, students have had the opportunity to meet with expert mentors and attended entrepreneurship trainings.
Diabetes at School Program
The "Diabetes at School Program," which is one of the projects launched to raise disease awareness for diabetes, is carried out since 2010 within the framework of Ministry of Health’s National Diabetes Control Program. The Diabetes at School Program, in cooperation with the Ministry of National Education, Ministry of Health and the Society for Pediatric Endocrinology and Diabetes and supported unconditionally by Sanofi, aims to raise awareness about diabetes among students, parents and teachers and improve diabetic children’s quality of life at school. To date, the program has reached 585 thousand teachers, 580 thousand parents and 7.5 million students in 25 thousand schools. The experience gathered through Diabetes at School Program, was used to co-create the KiDS program with the International Diabetes Federation. In 2017, trainings were held in Adana and Samsun with the participation of 750 people to raise awareness of Type 1 diabetes. In 2018, another training was organized in Eskişehir with the participation of 350 people.
The Fight against Diabetes Program
Within the context of Diabetes Support Program, we signed a protocol with the Public Health Institution. It aims to prevent healthy individuals from developing diabetes through “Prevention of Diabetes Trainings,” to train people with Type 2 diabetes through “In-class and Individual trainings and services” and to raise awareness of all diabetes patients and the healthy population at large through a “website”. As part of “In-class and Individual trainings and services,” we aim to deliver diabetes trainings in the cities, where we provide nursing services for diabetic patients once a week, at locations determined by the Public Health Institution. We aim to reach healthy individuals, in addition to diabetes patients, to explain what diabetes is, what needs to be done for prevention and what the complications would be if not treated properly. A public announcement was made and a comprehensive dedicated website developed to support the program. To date, public trainings were organized in twelve cities. The number of people trained reached 150,000.
RARE DISEASESRare diseases are defined as diseases that affect one out of 2,500 people. There are approximately 7,000 different types of rare diseases and disorders that are estimated to affect a total of more than 300 million people worldwide. 80% of rare diseases are genetic in origin, often chronic and life-threatening and present throughout a person’s life, even if symptoms do not immediately appear.
At Sanofi Genzyme, we believe that everyone living with a rare disease should be able to receive high-quality services, treatment and support. Thus, we have an integrated approach for our physicians, nurses and patients in order to fulfill the unmet medical needs in the rare disease area.
High Risk Testing - HRT Survey
The objective of High Risk Testing (HRT) survey is to conduct tests in order to understand the prevalence of rare diseases and their diagnoses in Turkey. Sanofi Genzyme unconditionally supports screening tests for Gaucher, Fabry, MPS I and Pompe diseases for which it offers treatment through its Global Diagnostic Support Program. Regular screening tests are carried out every year as part of the ongoing efforts since 2001. Over 10,000 patients with risk factors have been screened for diseases in the past three years. The survey helps to identify prevalence and provides epidemiological data for Turkey, and enables an early diagnosis before the disease reaches life-threatening dimensions.
GenAssist (Diagnostic Support Program)
Sanofi Genzyme provides treatment solutions in the field of rare diseases, Multiple Sclerosis (MS), oncology, hematology and immunology. The rare diseases group includes enzyme replacement therapies for Gaucher, Fabry, Pompe and MPS I. There are many new products under development in this area. Rare diseases are a group of diseases where awareness is low due to the fact their prevalence is low, they mimic many diseases, and require special methods for diagnosis. In order to diagnose these diseases, Sanofi Turkey has put in place a diagnostic support program. In 2018 an important step was taken in the field of local resource utilization and localization when we embarked on a collaboration with Düzen Laboratories.